Holen Sie sich die Stockscreener-App
7.79
0.00%
0.07
Schlusskurs vom Vortag:
$7.86
Offen:
$7.77
24-Stunden-Volumen:
157.78K
Relative Volume:
1.06
Marktkapitalisierung:
$163.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.38M
KGV:
-5.5248
EPS:
-1.41
Netto-Cashflow:
$-15.54M
1W Leistung:
-1.13%
1M Leistung:
-1.50%
6M Leistung:
+20.00%
1J Leistung:
+13.09%
1-Tages-Spanne:
$7.77
$8.11
1-Wochen-Bereich:
$7.70
$8.21
52-Wochen-Spanne:
$4.44
$11.80
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Firmenname
Nuvectis Pharma Inc
Sektor
Branche
Telefon
360-837-7232
Adresse
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Vergleichen Sie NVCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
7.83 | 168.82M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.87 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.74 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.03 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
581.51 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Maxim Group | Buy |
| 2025-03-17 | Eingeleitet | Laidlaw | Buy |
| 2022-07-13 | Eingeleitet | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten
Nuvectis Pharma Inc. Stock Analysis and ForecastHigh-yield investments - Autocar Professional
What analysts say about Nuvectis Pharma Inc. stockDynamic profit opportunities - Autocar Professional
What drives Nuvectis Pharma Inc. stock priceTriple-digit return opportunities - Autocar Professional
Is Nuvectis Pharma Inc. a good long term investmentRemarkable growth - jammulinksnews.com
(NVCT) On The My Stocks Page - news.stocktradersdaily.com
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - Yahoo.co
How Nuvectis Pharma Inc. stock performs during market volatilityFree Growth Investment Group - Newser
What makes Nuvectis Pharma Inc. stock price move sharplyHigh Confidence Trade Setups - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
When (NVCT) Moves Investors should Listen - news.stocktradersdaily.com
Nuvectis reports positive drug interaction study for cancer drug NXP900 By Investing.com - Investing.com Nigeria
Nuvectis Pharma, Inc. Announces Successful Completion of A Drug-Drug Interaction Study in Healthy Volunteers - MarketScreener
Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies - GlobeNewswire
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Purchased by Oppenheimer & Co. Inc. - Defense World
(NVCT) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Nuvectis Pharma, Inc.(NasdaqCM: NVCT) added to Russell 3000 Index - MarketScreener
Nuvectis Pharma (NASDAQ:NVCT) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Is Nuvectis Pharma, Inc. technically bullish or bearish? - MarketsMojo
(NVCT) Proactive Strategies - news.stocktradersdaily.com
Silicon Valley - FinancialContent
Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In - Seeking Alpha
Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases - Yahoo Finance
Insider Stock Buying Of Nuvectis Pharma Delivers Return On US$2.19m Investment - simplywall.st
Nuvectis Pharma Approves Proposals at Annual Meeting - TipRanks
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Sold by Two Sigma Investments LP - Defense World
Millennium Management LLC Reduces Holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World
(NVCT) Investment Analysis - news.stocktradersdaily.com
Squarepoint Ops LLC Invests $103,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World
Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect? - MSN
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Bought by Northern Trust Corp - Defense World
Cubist Systematic Strategies LLC Invests $34,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World
Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - GlobeNewswire
Nuvectis pharma investor Charles Mosseri Marlio buys $247k in stock By Investing.com - Investing.com India
Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nuvectis Pharma Inc-Aktie (NVCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mosseri Marlio Charles | 10% Owner |
Jun 18 '25 |
Buy |
8.05 |
28,043 |
225,746 |
2,976,203 |
| Mosseri Marlio Charles | 10% Owner |
Jun 17 '25 |
Buy |
8.11 |
5,399 |
43,786 |
2,948,160 |
| Mosseri Marlio Charles | 10% Owner |
May 12 '25 |
Buy |
8.11 |
21,167 |
171,664 |
2,942,761 |
| Mosseri Marlio Charles | 10% Owner |
May 06 '25 |
Buy |
8.59 |
12,444 |
106,955 |
2,896,565 |
| Mosseri Marlio Charles | 10% Owner |
May 07 '25 |
Buy |
8.59 |
12,317 |
105,770 |
2,908,882 |
| Mosseri Marlio Charles | 10% Owner |
May 08 '25 |
Buy |
8.65 |
2,650 |
22,922 |
2,911,532 |
| Mosseri Marlio Charles | 10% Owner |
Feb 07 '25 |
Buy |
5.00 |
240,000 |
1,200,000 |
2,884,121 |
| BENTSUR RON | Chairman & CEO |
Dec 24 '24 |
Buy |
4.65 |
4,500 |
20,925 |
3,270,924 |
| Mosseri Marlio Charles | 10% Owner |
Dec 13 '24 |
Buy |
4.70 |
17,000 |
79,900 |
2,612,000 |
| Poradosu Enrique | Chief Science & Business Off |
Nov 19 '24 |
Buy |
4.99 |
2,000 |
9,980 |
1,506,319 |
3.06%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):